Nolan Sean P. Insider Trading
Get the latest insider transactions of Nolan Sean P.. Nolan Sean P. is Director in Ventas, Inc. ($VTR) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and President & CEO in AveXis, Inc. ($AVXS) and Director in Taysha Gene Therapies, Inc. ($TSHA). Discover the current value of Nolan Sean P. shares.
Address: C/O INTERMUNE, INC. 3280 BAYSHORE BOULEVARD BRISBANE 94005CA
Nolan Sean P. is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| NLTX | Neoleukin Therapeutics, Inc. | Director | 0 | 0.00 |
| AVXS | AveXis, Inc. | President & CEO | 0 | 0.00 |
| VTR | Ventas, Inc. | Director | 7,555 | 466,974.55 |
| TSHA | Taysha Gene Therapies, Inc. | Director | 1,089,500 |
Insider Trading Transactions of Nolan Sean P.
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30 2020 | TSHA | Taysha Gene Therapies, In ... | Nolan Sean P. | Director | Buy | 0.00 | 1,089,500 | 0 | 1,089,500 |
| Sep 30 2020 | TSHA | Taysha Gene Therapies, In ... | Nolan Sean P. | Director | Buy | 0.00 | 1,601 | 0 | 1,091,101 |
| Sep 30 2020 | TSHA | Taysha Gene Therapies, In ... | Nolan Sean P. | Director | Option Exercise | 0.00 | 1,000,000 | 0 | 0 |
| Sep 30 2020 | TSHA | Taysha Gene Therapies, In ... | Nolan Sean P. | Director | Option Exercise | 0.00 | 1,470 | 0 | 0 |
| Sep 25 2020 | TSHA | Taysha Gene Therapies, In ... | Nolan Sean P. | Director | Option Exercise | 20.00 | 31,000 | 620,000 | 31,000 |
| May 20 2020 | VTR | Ventas, Inc. | Nolan Sean P. | Director | Buy | 0.00 | 5,424 | 0 | 7,555 |
| May 20 2020 | VTR | Ventas, Inc. | Nolan Sean P. | Director | Buy | 0.00 | 5,424 | 0 | 7,555 |
| May 07 2020 | NLTX | Neoleukin Therapeutics, I ... | Nolan Sean P. | Director | Option Exercise | 12.84 | 25,000 | 321,000 | 25,000 |
| Oct 15 2019 | AQXP | Neoleukin Therapeutics, I ... | Nolan Sean P. | Director | Option Exercise | 2.82 | 22,000 | 62,040 | 22,000 |
| Oct 15 2019 | AQXP | Neoleukin Therapeutics, I ... | Nolan Sean P. | Director | Option Exercise | 2.82 | 22,000 | 62,040 | 22,000 |
| Jul 29 2019 | VTR | Ventas, Inc. | Nolan Sean P. | Director | Buy | 67.03 | 2,131 | 142,841 | 2,131 |
| May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | 0.00 | 11,000 | 0 | 0 |
| May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | 15.94 | 728,300 | 11,609,102 | 0 |
| May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | 42.61 | 110,000 | 4,687,100 | 0 |
| May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | 77.24 | 96,000 | 7,415,040 | 0 |
| May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | 133.80 | 44,000 | 5,887,200 | 0 |
| May 09 2018 | AQXP | AQUINOX PHARMACEUTICALS, ... | Nolan Sean P. | Director | Option Exercise | 13.10 | 15,000 | 196,500 | 15,000 |
| Mar 27 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Buy | 0.00 | 11,000 | 0 | 11,000 |
| Mar 27 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | 133.80 | 44,000 | 5,887,200 | 44,000 |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Buy | 15.94 | 10,000 | 159,400 | 10,000 |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | 126.65 | 400 | 50,660 | 9,600 |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | 127.65 | 700 | 89,355 | 8,900 |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | 128.65 | 2,400 | 308,760 | 6,500 |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | 129.66 | 4,800 | 622,368 | 1,700 |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | 130.78 | 600 | 78,468 | 1,100 |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | 131.86 | 1,100 | 145,046 | 0 |
| Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | 15.94 | 10,000 | 159,400 | 728,300 |
| May 12 2017 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | 77.24 | 96,000 | 7,415,040 | 96,000 |
| May 10 2017 | AQXP | AQUINOX PHARMACEUTICALS, ... | Nolan Sean P. | Director | Option Exercise | 13.74 | 9,000 | 123,660 | 9,000 |
| Jun 22 2016 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | 42.61 | 110,000 | 4,687,100 | 110,000 |
| May 11 2016 | AQXP | AQUINOX PHARMACEUTICALS, ... | Nolan Sean P. | Director | Option Exercise | 7.73 | 7,500 | 57,975 | 7,500 |
| Mar 16 2015 | AQXP | AQUINOX PHARMACEUTICALS, ... | Nolan Sean P. | Director | Option Exercise | 12.03 | 10,000 | 120,300 | 10,000 |